Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumors
Quincy S. Chu, Nathaniel Bouganim, Caroline Fortier, Sara Zaknoen, John R. Stille, Jill D. Kremer, Eunice Yuen, Yu‐Hua Hui, Amparo de la Peña, Andrew Lithio, Patricia S. Smith, Gerald Batist
Topics & Concepts
MucositisMedicineTolerabilityResponse Evaluation Criteria in Solid TumorsAdverse effectNauseaInternal medicineDiarrheaGastroenterologyPhases of clinical researchPharmacokineticsVomitingToxicityOncologySurgeryMicrotubule and mitosis dynamicsCancer-related Molecular PathwaysNeuroblastoma Research and Treatments